All News

ACRmtg.jpg (keep)

ACR 2023 Convergence Brings Back the Poster Hall and 4 Day Meeting

d ACR

ACR Convergence 2023, the annual meeting of the American College of Rheumatology (ACR) and the world’s premier rheumatology experience, will be held Nov. 10 – 15 at the San Diego Convention Center in San Diego, CA.

Read Article
question-mark-1872634_640.jpg

ICYMI: What to do about pre-clinical RA?

d Robert Chao, MD

RheumNow Live’s 2023 conference led with this year’s hot topic of rheumatoid arthritis, especially what to do regarding pre-clinical RA.

Dr. Kevin Deane started the discussion by mapping out a very complex course of RA, beginning with a person’s genetic and environmental risk factors. What are Dr. Deane’s recommendations for management of pre-RA patients?

Read Article
pneumocystis,PJP

PJP Prophylaxis Needed with Steroids and Rituximab

d Jack Cush, MD

Pneumocystis jirovecii pneumonia (PJP) can be a life-threatening infection in immunocompromised patients. The 2023 EULAR Vasculitis guidelines recommends primary prophylaxis with antibiotics, especially in rheumatic disease patients receiving rituximab (RTX).

Read Article
Pharma marketing payments to MDs (none; < $100; >$100) correlated with Medicare billing of Intraarticular Hyaluronic Acid injx. In 20 501 MDs, 41.5% gave HA injx; Odds incr w/ payment <$100 (OR 2.06) or >$100 (OR 3.28); 12.7% & 21% more likely https://t.co/BP395xm0TW https://t.co/MDxT8Kl4kq

Links:

Dr. John Cush RheumNow ( View Tweet)
Observational study of cannabis use in 25 cancer pts (52% w/ colon/lung/breast CA) taking a 2-wks of ad libitum cannabis noted to have improvements in pain intensity, pain interference, sleep quality, & cognitive function,but no change in quality of life. https://t.co/iZjGMM1Pud https://t.co/vkOWVqfCYi

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumThoughts: An Opportunity to Say Yes Hi, I am Dr. Kathryn Dao ( @KDAO2011 ) a rheumatologist and senior editor for the RheumNow Women in Rheumatology Campaign. I wanted to share you with an opportunity. An Opportunity to Say Yes. https://t.co/dJKWFAASV9 https://t.co/Cm4vn563Pz

Links:

Dr. John Cush RheumNow ( View Tweet)
Romania to U.S.: My Journey to a Permanent Residency One in four practicing physicians in the United States are international medical graduates. I am one of them. Dr. Maria Danila shares her IMG experience. https://t.co/vpxyosojxc https://t.co/FrIuLyvgXS

Links:

Dr. John Cush RheumNow ( View Tweet)
Another review on the annual salaries of different specialists.... https://t.co/bkkcIR5pa5

Links:

Dr. John Cush RheumNow ( View Tweet)

Full Read comprehensive revie by Isenberg on what Rx work in SLE; they review RCT data on approved drugs and Rx in development: - Obinutuzumab - Dapirolizumab - Deucravacitinib - Litifilimab - Atacicept - Telitacicept https://t.co/jMLlRZuK6e https://t.co/8K0dYLieAH

Links:

Dr. John Cush RheumNow ( View Tweet)
UK's MHRA has followed EMA final ruling regarding new Safety recs & JAK inhibitors: - RE: tofacitinib, abrocitinib, baricitinib, upadacitinib & filgotinib use in chr inflammatory Dz. - avoid JAKi if no suitable alternative: age >=65, smokers, CV/CA Hx https://t.co/Y1vZPHPEPN https://t.co/odovKWebFV

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us this Tuesday for our the start of our May Tuesday Night Rheumatology focusing on Rheumatoid Arthritis: Revolutionary Advances in Therapy https://t.co/TbNYaGJ3sk https://t.co/DiJwjvUX1d

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: No is a complete sentence Dr. Rachel Tate ( @uptoTate ) shares her POV. https://t.co/0xzTobgmIQ https://t.co/YvEUMsqLyV

Links:

Dr. John Cush RheumNow ( View Tweet)
25 Great Women in Rheumatology This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? I'm sharing the responses. https://t.co/N1zqs3TJuv https://t.co/LXDxnXUaG9

Links:

Dr. John Cush RheumNow ( View Tweet)
Denosumab Reduces Type II Diabetes Risk The British Medical Journal has published a matched cohort analysis demonstrating that adults receiving denosumab had a lower risk of NIDDM compared with those taking oral bisphosphonates for osteoporosis. https://t.co/7SMjp258gX https://t.co/SAUmahwV9J

Links:

Dr. John Cush RheumNow ( View Tweet)
How Being a Patient Taught Me to Be a Better Doctor Dr. Marcella Ferrada ( @maferradastrong ) shares her experience having a rare disease and how it positively impacted her skills as a physician. https://t.co/eUHzPTjRv8 https://t.co/rTIfyLwVLY

Links:

Dr. John Cush RheumNow ( View Tweet)
A Danish national registry study compared RA pts taking JAKi (n 875) and bDMARDs (n 4247). They found similar rates of subsequent cancers (14.4 vs 12.9/ per 1000 PYRS); with a nonsignificant risk (HR1.41; CI 0.76, 2.37) https://t.co/wfrlAcij8x https://t.co/OvqKrHw5Wu

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: No is a complete sentence Dr. Rachel Tate ( @uptoTate ) shares her POV. https://t.co/TGcFuGl4Lp https://t.co/N0bItVkHjM

Links:

Dr. John Cush RheumNow ( View Tweet)
25 Great Women in Rheumatology This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? I'm sharing the responses. https://t.co/0d7SkgpcN5 https://t.co/nQVfs5oMFL

Links:

Dr. John Cush RheumNow ( View Tweet)
Narrative Medicine Dr. Aviya Lanis shares with us how narrative medicine helped her become a more engaging doctor. https://t.co/YJdsa50FBF https://t.co/7D3DiBnqaK

Links:

Dr. John Cush RheumNow ( View Tweet)
Metanalysis of Steroids in hosp community-acquired pneumonia (CAP). 18 studies 4661 pts. Corticosteroids reduced mortality in more severe CAP (RR 0.62; 0.45 to 0.85), but not less severe CAP(RR 1.08). Steroids lower need for mech ventilation, ICU https://t.co/dj7zABqQ3r https://t.co/Mb4g7ICdX9

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×